On Monday, Jefferies, a global financial services company, updated its outlook on shares of Sherwin-Williams (NYSE:), a major paint and coating manufacturer. The firm raised its price target on the company’s shares to $445 from the previous target of $425, while reiterating a Buy rating on the stock.
The adjustment in the stock price target reflects a positive stance on Sherwin-Williams’ future performance. The analyst at Jefferies noted that the current consensus estimates for the company’s third and fourth-quarter earnings are higher than their own forecasts. Specifically, consensus estimates are 2% higher for the third quarter and 9% higher for the fourth quarter compared to Jefferies’ projections.
Looking ahead to the next couple of years, the analyst pointed out that consensus forecasts are also above their predictions by 5% for the year 2025 and by 7% for 2026. Despite this, there has been limited opposition from investor meetings in the recent weeks, indicating that the market may have already accounted for a potential decrease in estimates.
The analyst’s commentary suggests that the market is anticipating a slight decline in Sherwin-Williams’ estimates for the years 2025 and 2026, possibly by 1% to 2%, following the release of third-quarter earnings and again after the fourth-quarter earnings call. Despite these anticipated adjustments, the firm’s maintained Buy rating and increased price target signify confidence in the company’s stock performance moving forward.
In other recent news, Sherwin-Williams has reported significant growth in consolidated sales, gross margin expansion, and diluted earnings per share, returning $613 million to shareholders, marking a 57% increase year-over-year, and revised its full-year earnings forecast upward. However, the company reduced sales guidance for the Consumer Brands Group due to underperformance in the DIY segment.
Sherwin-Williams also issued $850 million in senior notes, expected to be used for general corporate purposes. Sherwin-Williams stock was downgraded from Overweight to Sector Weight by KeyBanc, citing a “rich valuation” and limited upside for the stock in the near term.
Meanwhile, Mizuho increased its earnings per share (EPS) estimates for Sherwin-Williams for the years 2024 and 2025, reflecting confidence in the company’s ability to grow and sustain higher margins amidst market challenges.
BMO Capital Markets maintained an Outperform rating on Sherwin-Williams and raised the price target to $400, anticipating that the company will benefit from a rebound in the housing market over the coming year. However, BofA Securities maintained its Underperform rating on Sherwin-Williams, holding steady with a $291.00 price target, citing challenging market conditions and expected raw material cost increases.
KeyBanc maintained its Overweight rating and $410.00 price target for Sherwin-Williams, expressing confidence in the company’s ability to achieve revised medium-term targets and potential for significant margin improvement as market volumes recover. These are recent developments.
InvestingPro Insights
To complement Jefferies’ positive outlook on Sherwin-Williams (NYSE:SHW), recent data from InvestingPro offers additional context for investors. The company’s market capitalization stands at an impressive $97.96 billion, reflecting its significant presence in the chemicals industry.
One of the key InvestingPro Tips highlights that Sherwin-Williams has raised its dividend for 32 consecutive years, demonstrating a strong commitment to shareholder returns. This aligns well with the company’s solid financial position and Jefferies’ optimistic price target.
Moreover, Sherwin-Williams’ P/E ratio of 39.07 suggests that investors are willing to pay a premium for the stock, possibly due to its strong market position and growth prospects. This high valuation multiple corroborates with another InvestingPro Tip indicating that the stock is trading at a high earnings multiple.
For investors seeking a more comprehensive analysis, InvestingPro offers 17 additional tips on Sherwin-Williams, providing a deeper understanding of the company’s financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
